These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20737571)

  • 21. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do not count out external-beam radiation therapy for high-risk prostate cancer.
    Hamstra DA; Michalski JM; Roach M; Sandler HM
    J Clin Oncol; 2010 Oct; 28(28):e518-9; author reply e521-e522. PubMed ID: 20660824
    [No Abstract]   [Full Text] [Related]  

  • 23. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease.
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2005 Mar; 12(3):270-4. PubMed ID: 15828954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of hospital volume on cancer control after radical prostatectomy.
    Ellison LM; Trock BJ; Poe NR; Partin AW
    J Urol; 2005 Jun; 173(6):2094-8. PubMed ID: 15879850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adenocarcinoma of the prostate: pathological stage C. 2: Treatment].
    Flam T; Zerbib M; Steg A; Debré B
    J Urol (Paris); 1991; 97(7-8):305-8. PubMed ID: 1811022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary cancer and relapse rates following radical prostatectomy for prostate-confined cancer.
    Wesley D; Cox HF
    J Insur Med; 2007; 39(4):242-50. PubMed ID: 18522141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy.
    Rogers CG; Khan MA; Craig Miller M; Veltri RW; Partin AW
    Cancer; 2004 Dec; 101(11):2549-56. PubMed ID: 15470681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cancer of the prostate. Clinical estimation and results of radical prostatectomy].
    Anselmo G; Felici E; Merlo F; Fandella A; Bassi E; Maccatrozzo L; Checchin P
    J Urol (Paris); 1989; 95(7):419-22. PubMed ID: 2687397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
    Kamat AM; Babaian K; Cheung MR; Naya Y; Huang SH; Kuban D; Babaian RJ
    J Urol; 2003 Nov; 170(5):1860-3. PubMed ID: 14532793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant radiotherapy after surgery for pathologically advanced prostate cancer.
    Van der Kwast TH; Collette L; Bolla M
    J Clin Oncol; 2007 Dec; 25(35):5671-2. PubMed ID: 18065746
    [No Abstract]   [Full Text] [Related]  

  • 32. Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program.
    Varkarakis J; Pinggera GM; Sebe P; Berger A; Bartsch G; Horninger W
    Urology; 2004 Feb; 63(2):337-41. PubMed ID: 14972485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The treatment of locally advanced (T3) prostatic carcinoma using radical prostatectomy or radiotherapy. A review].
    van den Ouden D; Schröder FH
    Tijdschr Gerontol Geriatr; 1998 Apr; 29(2):74-9. PubMed ID: 9615377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer.
    Burkhardt JH; Litwin MS; Rose CM; Correa RJ; Sunshine JH; Hogan C; Hayman JA
    J Clin Oncol; 2002 Jun; 20(12):2869-75. PubMed ID: 12065564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phased array magnetic resonance imaging for staging clinically localised prostrate cancer.
    Borre M; Lundorf E; Marcussen N; Langkilde NC; Wolf H
    Acta Oncol; 2005; 44(6):589-92. PubMed ID: 16294442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
    Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI
    J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
    Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
    J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens.
    Poulos CK; Daggy JK; Cheng L
    Cancer; 2004 Aug; 101(3):527-32. PubMed ID: 15274065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer.
    Liu L; Coker AL; Du XL; Cormier JN; Ford CE; Fang S
    J Surg Oncol; 2008 Jun; 97(7):583-91. PubMed ID: 18381603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.